"Risk Assessment" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The qualitative or quantitative estimation of the likelihood of adverse effects that may result from exposure to specified health hazards or from the absence of beneficial influences. (Last, Dictionary of Epidemiology, 1988)
| Descriptor ID |
D018570
|
| MeSH Number(s) |
E05.318.740.600.800.715 N04.452.871.715 N05.715.360.750.625.700.690 N06.850.505.715 N06.850.520.830.600.800.715
|
| Concept/Terms |
Risk Assessment- Risk Assessment
- Assessments, Risk
- Risk Assessments
- Health Risk Assessment
- Assessment, Health Risk
- Assessments, Health Risk
- Health Risk Assessments
- Risk Assessment, Health
- Risk Assessments, Health
- Assessment, Risk
Benefit-Risk Assessment- Benefit-Risk Assessment
- Assessment, Benefit-Risk
- Assessments, Benefit-Risk
- Benefit Risk Assessment
- Benefit-Risk Assessments
- Risk-Benefit Assessment
- Assessment, Risk-Benefit
- Assessments, Risk-Benefit
- Risk Benefit Assessment
- Risk-Benefit Assessments
|
Below are MeSH descriptors whose meaning is more general than "Risk Assessment".
Below are MeSH descriptors whose meaning is more specific than "Risk Assessment".
This graph shows the total number of publications written about "Risk Assessment" by people in this website by year, and whether "Risk Assessment" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 1 | 5 | 6 |
| 1996 | 1 | 10 | 11 |
| 1997 | 1 | 8 | 9 |
| 1998 | 0 | 4 | 4 |
| 1999 | 0 | 10 | 10 |
| 2000 | 1 | 12 | 13 |
| 2001 | 0 | 18 | 18 |
| 2002 | 1 | 20 | 21 |
| 2003 | 2 | 35 | 37 |
| 2004 | 4 | 36 | 40 |
| 2005 | 5 | 39 | 44 |
| 2006 | 5 | 59 | 64 |
| 2007 | 6 | 59 | 65 |
| 2008 | 8 | 82 | 90 |
| 2009 | 3 | 67 | 70 |
| 2010 | 9 | 75 | 84 |
| 2011 | 7 | 85 | 92 |
| 2012 | 9 | 84 | 93 |
| 2013 | 6 | 55 | 61 |
| 2014 | 8 | 70 | 78 |
| 2015 | 8 | 81 | 89 |
| 2016 | 11 | 88 | 99 |
| 2017 | 7 | 92 | 99 |
| 2018 | 21 | 89 | 110 |
| 2019 | 22 | 103 | 125 |
| 2020 | 9 | 109 | 118 |
| 2021 | 7 | 68 | 75 |
| 2022 | 1 | 26 | 27 |
| 2023 | 0 | 32 | 32 |
| 2024 | 2 | 67 | 69 |
| 2025 | 0 | 15 | 15 |
To return to the timeline,
click here.
Below are the most recent publications written about "Risk Assessment" by people in Profiles.
-
Preoperative Biomarkers and Thromboelastometry According to Caprini Venous Thromboembolism Risk Stratification in Bariatric Patients: Are Clinical Risk Assessments Enough? J Am Coll Surg. 2025 Jul 01; 241(1):67-76.
-
Statin initiation and early stroke recurrence in the Platelet-Oriented Inhibition in New TIA and Minor Ischemic Stroke Trial (POINT) trial population. J Stroke Cerebrovasc Dis. 2025 Jul; 34(7):108349.
-
Machine Learning for Predicting Critical Events Among Hospitalized Children. JAMA Netw Open. 2025 May 01; 8(5):e2513149.
-
Biases in the performance of FRAX without BMD in predicting fracture risk in a multiethnic population with diabetes: the Diabetes and Aging Study. J Bone Miner Res. 2025 Apr 21; 40(4):478-491.
-
Stroke risk prediction in symptomatic anterior circulation ICAD: Analysis of regional QMRA flow from the MYRIAD study. J Stroke Cerebrovasc Dis. 2025 Jun; 34(6):108322.
-
A Comparison of Stockholm3, Serum Biomarkers, and Risk Calculators to Predict Prostate Cancer in a Racially and Ethnically Diverse Cohort: Evaluation of the Stockholm3 Multiethnic SEPTA Trial. J Urol. 2025 May; 213(5):590-599.
-
Genetic and Nongenetic Risk Factors for Breast Cancer Risk Estimation. JAMA Netw Open. 2025 Apr 01; 8(4):e255804.
-
TP53 -Mutated Myeloid Neoplasms: 2024 Update on Diagnosis, Risk-Stratification, and Management. Am J Hematol. 2025 Jun; 100 Suppl 4:88-115.
-
Psychosocial Stress and Risk for Intracerebral Hemorrhage in the ERICH (Ethnic/Racial Variations of Intracerebral Hemorrhage) Study. J Am Heart Assoc. 2025 Mar 18; 14(6):e024457.
-
Effect of Sodium-Glucose Cotransporter-2 Inhibitors on the Progression of Aortic Stenosis. JACC Cardiovasc Interv. 2025 Mar 24; 18(6):738-748.